Cold & Cough Remedies (Pharmacies) - Africa

Revenue in the Cold & Cough Remedies market is projected to reach US$1.54bn in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 8.48%, resulting in a market volume of US$2.32bn by 2029.
In global comparison, most revenue will be generated China (US$7.83bn in 2024).
In relation to total population figures, per person revenues of US$1.19 are generated in 2024.

Definition:
The Cold and Cough market encompasses a range of over-the-counter (OTC) products sold through pharmacies. These products include both natural and synthetic agents designed to alleviate symptoms related to cough, cold, sore throat, expectorants, and flu-like infections. The market includes various forms of medication such as pills, syrups, lozenges, sprays, ointments, and granulates for both external and internal usage. However, the market excludes prescription medicines, products contrary to state regulations, or those not explicitly designed for cold or cough relief, such as painkillers. Some of the leading products in this market include nose sprays, Mucosolvan syrup, Grippostad C, Sinupret forte, Gelomyrtol, Dolo-Dobendan, Aspirin Complex, Bepanthen nose and eye cream, ACC Akut, Neo-Angin, Vick Vaporup, and Isla Moos. This market exclusively covers product sales through pharmacies.

Additional Information:
The Cold and Cough market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Natural and synthetic agents
In the form of pills, syrups, creams, lozenges, sprays and granulate
Expectorants and remedies to relieve cough

Prescription medicines
Homeopathic remedies
Painkillers
Candy

The Cold & Cough Remedies (Pharmacies) market in Africa is experiencing significant growth and development due to changing customer preferences, emerging trends, and local special circumstances.

Customer preferences: Customers in Africa are increasingly seeking over-the-counter remedies for cold and cough symptoms. This shift in preference can be attributed to various factors, including the convenience of purchasing medication without a prescription and the increasing awareness of self-care practices. Additionally, the affordability of these remedies compared to prescription medications is also driving customer preferences towards cold and cough remedies available in pharmacies.

Trends in the market: One of the key trends in the Cold & Cough Remedies (Pharmacies) market in Africa is the rising demand for natural and herbal remedies. Customers are becoming more conscious of the ingredients in the products they consume and are opting for remedies that are perceived to be safer and have fewer side effects. This trend is driven by the growing popularity of traditional medicine and the belief that natural remedies provide holistic health benefits. Another trend observed in the market is the increasing availability and accessibility of cold and cough remedies in pharmacies across Africa. As the healthcare infrastructure improves and more pharmacies are established, customers have greater access to a wide range of cold and cough remedies. This trend is further supported by the expansion of pharmacy chains and the growing presence of multinational pharmaceutical companies in the region.

Local special circumstances: The prevalence of infectious diseases and the high incidence of respiratory illnesses in Africa contribute to the demand for cold and cough remedies. The continent experiences a significant burden of diseases such as tuberculosis, pneumonia, and influenza, which often manifest with cold and cough symptoms. As a result, customers in Africa are more likely to seek remedies to alleviate these symptoms and manage their respiratory health. Furthermore, the diverse cultural and traditional practices in Africa influence the demand for specific cold and cough remedies. Traditional medicine plays a significant role in many African communities, and customers often rely on herbal remedies and traditional healing practices to treat cold and cough symptoms. This cultural preference for traditional remedies creates a unique market dynamic in the region.

Underlying macroeconomic factors: The growing middle class and increasing disposable income in Africa are driving the demand for cold and cough remedies. As more individuals have access to healthcare services and can afford over-the-counter medications, the market for these remedies expands. Additionally, the urbanization and population growth in Africa contribute to the rising demand for cold and cough remedies, as urban areas are often more exposed to pollution and respiratory illnesses. Furthermore, the improving healthcare infrastructure and regulatory environment in Africa support the growth of the Cold & Cough Remedies (Pharmacies) market. Governments are implementing policies to ensure the quality and safety of pharmaceutical products, which instills confidence in customers and encourages them to purchase remedies from pharmacies. In conclusion, the Cold & Cough Remedies (Pharmacies) market in Africa is developing due to changing customer preferences, emerging trends, local special circumstances, and underlying macroeconomic factors. The demand for over-the-counter remedies, particularly natural and herbal options, is on the rise, driven by the convenience, affordability, and increasing awareness of self-care practices. The prevalence of respiratory illnesses and the cultural preference for traditional remedies also contribute to the growth of the market. Additionally, the growing middle class, increasing disposable income, and improving healthcare infrastructure in Africa support the expansion of the Cold & Cough Remedies (Pharmacies) market.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.